Hormonal and immunologic risk factors for the development of rheumatoid arthritis: An integrative physiopathogenetic perspective

Rheumatic Disease Clinics of North America

Volumn 26, Issue 4, 2000, Pages 775-803

  Masi, Alfonse T ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCOCORTICOID; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; RHEUMATOID FACTOR;

CLINICAL TRIAL; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; META ANALYSIS; ONSET AGE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE;

EID: 0033777801     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70169-1     Document Type: Article

References (109)

1. Rheumatoid factors antedating clinical rheumatoid arthritis
2. Serum immunoglobulins and the risk of rheumatoid arthritis
3. When does rheumatoid disease start?
4. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
5. Late systemic consequences of neuroendocrine-immune imbalance in rheumatoid arthritis
6. Elevated serum vascular endothelial growth factor in early arthritis
7. Immune-neuro-endocrine interactions: Facts and hypotheses
8. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire
9. The immunologic homunculus in rheumatoid arthritis
10. Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study
11. A genetic theory of inflammatory polyarthritis
12. Postmenopausal hormones and the incidence of rheumatoid arthritis
13. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: Differences related to age and sex
14. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon®) in patients with rheumatoid arthritis
15. Adrenal androgens and aging: In vitro studies
16. The role of extra-adrenal factors in adrenal androgen excess: In vitro studies
17. Aging-associated endothelial dysfunction in humans is reversed by L-arginine
18. The influence of the hormonal system in pediatric rheumatic diseases
19. Neuroendocrine immune responses to inflammation: The concept of the neuroendocrine immune loop
20. Reciprocal interactions between the neuroendocrine and immune systems during inflammation
21. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
22. A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1
23. Different roles for androgens and estrogens in the susceptibility of autoimmune rheumatic diseases
24. Estrogens, the immune response and autoimmunity
25. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids
26. Sex hormones, glucocorticoids and autoimmunity: Facts and hypotheses
27. Protective effect of androgens against inflammation induced cartilage degradation in male rodents
28. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells
29. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs
30. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study
31. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus
32. Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: Rejection of the unifying-shared-epitope hypothesis
33. Lymphoid and microvascular dysfunction in experimental models of rheumatoid inflammation
34. Observational studies of cause-effect relationships: An analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of rheumatoid arthritis
35. Angiogenesis in cancer, vascular, rheumatoid and other disease
36. Gonadal and adrenal sex steroids in ankylosing spondylitis
37. Persistence of mild, early inflammatory arthritis
38. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation
39. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor
40. The influence of HLA-DRB 1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis
41. HLA-linked rheumatoid arthritis
42. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis
43. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis
44. Exogenous sex hormones and the risk of rheumatoid arthritis
45. Twin studies in rheumatic diseases
46. Occurrence of rheumatoid arthritis is not increased in the first degree relatives of a population based inception cohort of inflammatory polyarthritis
47. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis
48. Hormonal alterations in rheumatoid arthritis, including effects of pregnancy
49. ACTH, glucocorticoid and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation
50. Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity
51. Sex hormones and immune responses
52. Age, sex, and the familial risk of rheumatoid arthritis
53. Sex hormones and systemic lupus erythematosus
54. Heberden Oration, 1969. Rheumatoid arthritis-nature or nurture?
55. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis
56. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function
57. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity
58. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins
59. Rheumatoid factor isotypes in monozygotic and dizygotic twins discordant for rheumatoid arthritis
60. Incidence of rheumatoid arthritis: Do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis?
61. Sex hormones and rheumatoid arthritis: Cause or effect relationships in a complex pathophysiology?
62. Cigarette smoking and other acquired risk factors for rheumatoid arthritis
63. Epidemiology of the rheumatic diseases
64. Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 (Reumacon®) as a single drug therapy of moderately active rheumatoid arthritis patients
65. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis
66. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems
67. Perturbations of hypothalamic-pituitary-gonadal (HPG) axis and adrenal androgen (AA) functions in rheumatoid arthritis
68. Adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis: A clue to its physiopathogenesis?
69. Decreased serum dehydroepiandrosterone sulfate (DHAS) levels before onset of RA in younger, premenopausal women: A controlled, prospective study
70. Decreased serum dehydroepiandrosterone sulfate (DHEAS) levels in menstruating women prior to onset of RA before age 50: Independent reference laboratory assays validate previous significant results
71. Dissociation of serum dehydroepiandrosterone sulfate (DHEAS) and cortisol levels in younger premenopausal women prior to onset of rheumatoid arthritis (RA) before age 50: Results of a prospective, controlled study
72. Integrated hormonal-immunological-vascular (H-I-V triad) systems interactions in the rheumatic diseases
73. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion
74. Low serum dehydroepiandrosterone sulfate (DHAS) levels, rheumatoid factor (RF) and elevated serum tumor necrosis factor α (TNFα) without cytokine receptor (CR) elevations predict long-term onset of RA in women: A controlled, prospective study
75. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: Physiopathogenetic and therapeutic perspectives
76. Precursor risk markers (RMs) were identified in 94% of 18 pre-rheumatoid arthritis (pre-RA) males compared to 28% of 72 matched controls (CN) in a community-based, prospective study
77. Independent risk markers (RMs) for RA onset in males include: Rheumatoid arthritis (RA) in a first degree relative (FDR+); rheumatoid factor (RF +); combined low serum cortisol and testosterone (low CandT); and heavy cigarette smoking (C530 + / d
78. A positive history of rheumatoid arthritis (RA) in a first degree relative (FDR) or a positive serological predictor for RA prior to disease onset before age 50 were uniformly present in a sample of younger, premenopausal incident cases: Results of a prospective, controlled study
79. +) of 30+ daily are independent long-term predictors of RA
80. Smoking and rheumatoid arthritis: Comment on the letter by McDonagh and Walker
81. A genetic theory of inflammatory polyarthritis
82. Smoking and rheumatoid arthritis-observations from a multicase family study: Comment on the article by Silman et al
83. The aging immune system: Primer and prospectus
84. Blockade of vascular endothelial growth factor activity attenuates murine collagen-induced arthritis
85. The role of the endothelium in rheumatoid arthritis and scleroderma
86. Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS
87. Genetic epidemiology of rheumatoid disease
88. The germline and somatic genetic basis for rheumatoid arthritis
89. Gonadal steroids and immunity
90. Hormones, pregnancy and rheumatoid arthritis
91. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
92. The vascular endothelial system (VES) in the pathogenesis of inflammation and systemic rheumatic diseases: Relationship to the neuroendocrine system
93. Female sex hormones and rheumatoid arthritis. Proceedings of an International Workshop, Leiden, The Netherlands, 20-21 March, 1989
94. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study
95. Vascular lesions in rheumatoid arthritis
96. The protective effect of the oral contraceptive pill on rheumatoid arthritis: An overview of the analytical epidemiological studies using meta-analysis
97. Does estrogen replacement therapy protect against rheumatoid arthritis?
98. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: Results from a large, population-based study
99. The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera
100. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 Patients treated up to 12 months
101. HLA-DR4 does not predispose to higher amounts of rheumatoid factor in healthy persons
102. Disease mechanisms in rheumatoid arthritis: Gene dosage effect of HLA-DR haplotypes
103. Neuroendocrine-immune system interactions and autoimmunity
104. Neuroendocrine correlates of aging
105. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis
106. Decreased conversion of androgens to normal 17-ketosteroid metabolites: A nonspecific consequence of illness